Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective study of ten years of dystocic calving assisted by veterinarians in a bovine semi-extensive production grass-based system.

Research in veterinary science·2026
Same author

Coleaf, an image recognition-driven approach facilitates the genome-wide association study with tea leaf morphology.

Plant methods·2026
Same author

Reducing the Diagnostic Time for Childhood Cancer in Peru: A Hospital-Based Registry Analysis Four Years After Implementation of the Global Initiative for Childhood Cancer.

Pediatric blood & cancer·2025
Same author

The miR444f Regulates Root Development via Gibberellin Metabolic Pathway in Rice.

Plant, cell & environment·2025
Same author

The Effects of Asthma, Anxiety, and Depression on Sleep Outcomes Among Youth in Puerto Rico.

Journal of clinical psychology in medical settings·2025
Same author

In silico evaluation of pramlintide dosing algorithms in artificial pancreas systems.

Computers in biology and medicine·2025

Related Experiment Video

Updated: May 9, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

Warfarin initiation nomograms for venous thromboembolism.

Pedro Garcia1, Wilson Ruiz, Cesar Loza Munarriz

  • 1Department ofMedicine,HospitalNacionalAlmanzorAguinagaAsenjo,Chiclayo, Peru.pedro.peterone99@gmail.com.

The Cochrane Database of Systematic Reviews
|July 11, 2013
PubMed
Summary

This study compared 10-mg versus 5-mg warfarin loading doses for venous thromboembolism (VTE). While a 10-mg dose may achieve therapeutic anticoagulation faster, results showed considerable uncertainty regarding optimal initial warfarin dosing for VTE patients.

More Related Videos

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Related Experiment Videos

Last Updated: May 9, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), is a prevalent condition in hospitalized patients.
  • Optimal initial warfarin dosing remains controversial, impacting the speed of achieving therapeutic anticoagulation and potentially treatment costs.
  • Rapid achievement of a therapeutic international normalized ratio (INR) with warfarin minimizes the need for parenteral anticoagulation.

Purpose of the Study:

  • To compare the efficacy of a 10-mg warfarin nomogram versus a 5-mg warfarin nomogram in patients diagnosed with VTE.
  • To evaluate the impact of different initial warfarin dosing strategies on achieving therapeutic INR levels and clinical outcomes.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) comparing 10-mg and 5-mg warfarin initiation nomograms in VTE patients.
  • Searches were conducted across multiple databases including Cochrane CENTRAL, PubMed, and LILACS, with additional contact to pharmaceutical companies.
  • Data on therapeutic INR achievement, recurrent VTE, bleeding events, and hospital stay were extracted and analyzed.

Main Results:

  • Four RCTs with 494 participants were included. Three studies (383 participants) reported on achieving therapeutic INR by day five.
  • A 10-mg warfarin nomogram showed a significant benefit in achieving therapeutic INR by day five (RR 1.27, 95% CI 1.05 to 1.54), but with substantial heterogeneity (I² = 90%).
  • No significant differences were observed in recurrent VTE, major or minor bleeding events, or length of hospital stay between the two dosing nomograms.

Conclusions:

  • Considerable uncertainty exists regarding the optimal initial warfarin loading dose (10-mg vs. 5-mg) for achieving therapeutic INR in patients with acute VTE.
  • The heterogeneity observed across the analyzed studies limits the certainty of conclusions regarding the best warfarin initiation nomogram.
  • Further research may be needed to clarify the optimal dosing strategy for warfarin initiation in VTE management.